3 Top Blue-Chip Stocks For Next Year: AstraZeneca plc, Burberry Group plc And Tesco PLC

These 3 stocks could deliver better-than-expected performances next year: AstraZeneca plc (LON: AZN), Burberry Group plc (LON: BRBY) and Tesco PLC (LON: TSCO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

AstraZeneca

While the decision by US lawmakers to close the so-called ‘tax inversion’ loophole makes it less likely for a US firm to bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US), there is still the potential for M&A activity. That’s because AstraZeneca is building a hugely impressive pipeline that could deliver stunning long-term top and bottom line growth for the company.

For example, it has acquired Bristol-Myers Squibb’s share of the diabetes alliance that could be a key growth area for drugs and treatments over the long run. And, with a number of its peers struggling to post meaningful sales growth, a bid for AstraZeneca is very much a distinct possibility for 2015.

Although AstraZeneca’s earnings are set to slip by a further 4% next year, investors seem willing to look beyond the shorter term and look ahead to a period of stronger growth. With sector peer Shire trading on a price to earnings (P/E) ratio of around 19.8, there is still scope for AstraZeneca to see its rating adjusted upwards from the current 16.8 during the course of the next year.

Burberry

With Burberry (LSE: BRBY) being heavily focused on emerging markets for its sales, the economic outlook for China really matters. And, with the world’s second biggest economy experiencing a period of slower than anticipated growth, it is little wonder that Burberry’s bottom line is forecast to fall by 1% in the current year.

However, with China making what is rumoured to be the first in a series of interest rate cuts, 2015 is expected to be a much better year for consumer stocks such as Burberry. In fact, it is expected to post earnings growth of around 9% next year and, with shares in Burberry trading on a P/E ratio of 20.7, they seem to offer good value for money when the strength of the brand and its longer-term potential are taken into account. As a result, Burberry’s shares could perform well next year.

Tesco

Clearly, 2014 has been a highly challenging year for Tesco (LSE: TSCO), with the misstatement of forecasts and continued challenging trading conditions causing its shares to fall by 50% since the turn of the year. Furthermore, there could be additional pain to come for investors in the short run, with new CEO Dave Lewis yet to state his strategy for rationalising the business and turning it around.

However, the market seems to be expecting trading conditions to worsen indefinitely for Tesco, which is unlikely to happen. Certainly, sales will not increase rapidly in a short space of time but, with wage rises being ahead of inflation, the focus on price among shoppers may begin to recede during the course of the next year. With investor sentiment being so negative in regard to Tesco’s future prospects, any positive surprise could be well rewarded via a higher share price. As a result, Tesco could prove to be a stock worth holding during the next year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Tesco. The Motley Fool UK has recommended Burberry. The Motley Fool UK owns shares of Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s how I’m using a £20k ISA to target £11k+ in income 30 years from now

Is it realistic to put £20k in an ISA now and earn over half that amount every year in passive…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

If I could only keep 5 UK stocks from my portfolio I’d save these

Harvey Jones is running through his portfolio of top UK stocks to see which ones he couldn't bear to do…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

I’m aiming for a million buying unexciting shares!

By investing regularly in long-established, proven and even rather dull businesses, this writer plans to aim for a million. Here's…

Read more »

Investing Articles

3 things to consider before you start investing

Our writer draws on his stock market experience to consider a few vital lessons he would use to start investing…

Read more »

Investing Articles

Will this lesser-known £28bn growth stock be joining the FTSE 100 soon?

As the powers that be plan a reorganisation of Footsie listing rules, this massive under-the-radar growth stock could find its…

Read more »

Investing Articles

Fools wouldn’t touch these 5 FTSE 350 flops with a bargepole – how come I own 3 of them?

Harvey Jones took a chance on three struggling FTSE 350 stocks in the hope that they'd stage a dramatic recovery.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

How I’m trying to make a million from passive income

Invest as much as possible, regularly, and use the passive income to plough back into more shares. Here's how millionaires…

Read more »

Investing Articles

I’d buy 30,434 shares of this UK dividend stock to target £175 a month in passive income

A top insider has spent over £1m buying this 9%-yielding passive income share over the last year. Roland Head explains…

Read more »